STRATEGIC MARKETING INNOVATIONS

Lobbying for CIVICA RX · Pharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Utah · House · Senate · $10,000.00 income · posted Oct 20, 2025

Lobbying activity 2

Health Issues

Onshoring domestic pharmaceutical industrial base

Defense

Onshoring domestic pharmaceutical industrial base

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.